318 related articles for article (PubMed ID: 26834735)
1. Inducing and Administering Tregs to Treat Human Disease.
Perdigoto AL; Chatenoud L; Bluestone JA; Herold KC
Front Immunol; 2015; 6():654. PubMed ID: 26834735
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of dendritic cells and anti-CD3/CD28 expanded regulatory T cells for application in transplantation.
Zeng M; Guinet E; Nouri-Shirazi M
Transpl Immunol; 2009 Dec; 22(1-2):82-92. PubMed ID: 19635560
[TBL] [Abstract][Full Text] [Related]
3. Antigen-Specific Regulatory T Cells and Low Dose of IL-2 in Treatment of Type 1 Diabetes.
Pham MN; von Herrath MG; Vela JL
Front Immunol; 2015; 6():651. PubMed ID: 26793191
[TBL] [Abstract][Full Text] [Related]
4. Regulatory T cells in immune-mediated renal disease.
Ghali JR; Wang YM; Holdsworth SR; Kitching AR
Nephrology (Carlton); 2016 Feb; 21(2):86-96. PubMed ID: 26206106
[TBL] [Abstract][Full Text] [Related]
5. FOXP3+ regulatory T cells: from suppression of rejection to induction of renal allograft tolerance.
Dummer CD; Carpio VN; Gonçalves LF; Manfro RC; Veronese FV
Transpl Immunol; 2012 Jan; 26(1):1-10. PubMed ID: 21939765
[TBL] [Abstract][Full Text] [Related]
6. Dendritic cells expand antigen-specific Foxp3+ CD25+ CD4+ regulatory T cells including suppressors of alloreactivity.
Yamazaki S; Inaba K; Tarbell KV; Steinman RM
Immunol Rev; 2006 Aug; 212():314-29. PubMed ID: 16903923
[TBL] [Abstract][Full Text] [Related]
7. Regulatory T Cells in Hepatic Immune Tolerance and Autoimmune Liver Diseases.
Herkel J
Dig Dis; 2015; 33 Suppl 2():70-4. PubMed ID: 26642346
[TBL] [Abstract][Full Text] [Related]
8. Human and Mouse CD8(+)CD25(+)FOXP3(+) Regulatory T Cells at Steady State and during Interleukin-2 Therapy.
Churlaud G; Pitoiset F; Jebbawi F; Lorenzon R; Bellier B; Rosenzwajg M; Klatzmann D
Front Immunol; 2015; 6():171. PubMed ID: 25926835
[TBL] [Abstract][Full Text] [Related]
9. Impaired control of effector T cells by regulatory T cells: a clue to loss of oral tolerance and autoimmunity in celiac disease?
Hmida NB; Ben Ahmed M; Moussa A; Rejeb MB; Said Y; Kourda N; Meresse B; Abdeladhim M; Louzir H; Cerf-Bensussan N
Am J Gastroenterol; 2012 Apr; 107(4):604-11. PubMed ID: 22108452
[TBL] [Abstract][Full Text] [Related]
10. The benefits of diversity: heterogenous DC populations allow for both immunity and tolerance.
Moore JR
J Theor Biol; 2014 Sep; 357():86-102. PubMed ID: 24816181
[TBL] [Abstract][Full Text] [Related]
11. Use of CFSE to monitor ex vivo regulatory T-cell suppression of CD4+ and CD8+ T-cell proliferation within unseparated mononuclear cells from malignant and non-malignant human lymph node biopsies.
Hilchey SP; Bernstein SH
Immunol Invest; 2007; 36(5-6):629-48. PubMed ID: 18161522
[TBL] [Abstract][Full Text] [Related]
12. Regulatory T-cell physiology and application to treat autoimmunity.
Tang Q; Bluestone JA
Immunol Rev; 2006 Aug; 212():217-37. PubMed ID: 16903917
[TBL] [Abstract][Full Text] [Related]
13. CD4 blockade directly inhibits mouse and human CD4(+) T cell functions independent of Foxp3(+) Tregs.
Mayer CT; Huntenburg J; Nandan A; Schmitt E; Czeloth N; Sparwasser T
J Autoimmun; 2013 Dec; 47():73-82. PubMed ID: 24055067
[TBL] [Abstract][Full Text] [Related]
14. Generation of Human Alloantigen-Specific Regulatory T Cells Under Good Manufacturing Practice-Compliant Conditions for Cell Therapy.
Cheraï M; Hamel Y; Baillou C; Touil S; Guillot-Delost M; Charlotte F; Kossir L; Simonin G; Maury S; Cohen JL; Lemoine FM
Cell Transplant; 2015; 24(12):2527-40. PubMed ID: 25198125
[TBL] [Abstract][Full Text] [Related]
15. Regulatory T cells: a review.
Dasgupta A; Saxena R
Natl Med J India; 2012; 25(6):341-51. PubMed ID: 23998865
[TBL] [Abstract][Full Text] [Related]
16. Rapamycin, unlike cyclosporine A, enhances suppressive functions of in vitro-induced CD4+CD25+ Tregs.
Bocian K; Borysowski J; Wierzbicki P; Wyzgal J; Klosowska D; Bialoszewska A; Paczek L; Górski A; Korczak-Kowalska G
Nephrol Dial Transplant; 2010 Mar; 25(3):710-7. PubMed ID: 19903662
[TBL] [Abstract][Full Text] [Related]
17. Ex vivo-expanded but not in vitro-induced human regulatory T cells are candidates for cell therapy in autoimmune diseases thanks to stable demethylation of the FOXP3 regulatory T cell-specific demethylated region.
Rossetti M; Spreafico R; Saidin S; Chua C; Moshref M; Leong JY; Tan YK; Thumboo J; van Loosdregt J; Albani S
J Immunol; 2015 Jan; 194(1):113-24. PubMed ID: 25452562
[TBL] [Abstract][Full Text] [Related]
18. Adoptive cell therapy using in vitro generated human CD4+ CD25+ regulatory t cells with indirect allospecificity to promote donor-specific transplantation tolerance.
Jiang S; Tsang J; Lechler RI
Transplant Proc; 2006 Dec; 38(10):3199-201. PubMed ID: 17175221
[TBL] [Abstract][Full Text] [Related]
19. Self-tolerance and autoimmunity in a regulatory T cell model.
Alexander HK; Wahl LM
Bull Math Biol; 2011 Jan; 73(1):33-71. PubMed ID: 20195912
[TBL] [Abstract][Full Text] [Related]
20. Role of regulatory T cells for the treatment of type 1 diabetes mellitus.
Jaeckel E; Mpofu N; Saal N; Manns MP
Horm Metab Res; 2008 Feb; 40(2):126-36. PubMed ID: 18283631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
